TIGR-tas cytosine base editing system and application thereof
By fusing cytosine deaminase with the TIGR-Tas system effector protein parTasR and utilizing mismatch-programmed tigRNA, the TIGR-Tas cytosine base editing system was constructed, solving the problems of PAM restriction and low editing efficiency. This system achieves efficient and controllable cytosine base editing, making it suitable for disease model construction and gene therapy.
Patent Information
- Application Number
- CN202610808785.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-06-05
- Publication Date
- 2026-08-25
AI Technical Summary
Existing RNA-guided nucleases rely on specific protospacer sequence neighbor motifs (PAMs) to recognize limited target ranges. The TIGR-Tas framework has low editing efficiency in mammalian cells and suffers from increased byproducts, making it difficult to achieve efficient and controllable cytosine base editing.
By fusing cytosine deaminase with the TIGR-Tas system effector protein parTasR and combining it with mismatch-programmed tigRNA, parTasR was induced to enter a nickase-like catalytic state, thus constructing a PAM-independent TIGR-Tas cytosine base editing system, which was optimized to TIGR-Tas-CBE-V3.
It overcomes the limitations of PAM, expands the target range, significantly improves editing efficiency, reduces double-strand break-related byproducts, and maintains good genome and transcriptome specificity, making it suitable for disease model construction and gene therapy.